Sales rise 65.10% to Rs 368.95 crore
Sales decline 29.39% to Rs 22.63 crore
Sales rise 73.74% to Rs 21.11 crore
Suven Life Sciences consolidated net loss stood at Rs 33.69 crore in Q3 FY22 as compared to a net loss of Rs 24.39 crore in Q3 FY21.
Sales rise 26.59% to Rs 27.99 crore
Sales rise 15.18% to Rs 573.91 crore
Sales rise 6.00% to Rs 1.59 crore
Sales rise 7.99% to Rs 345.51 crore
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
